Printed from https://www.whatdotheyknow.com/user/dominique_anderson on January 22, 2021 16:25

Dominique Anderson

Joined WhatDoTheyKnow in 2018

Send message to Dominique Anderson

Sign in to change password, subscriptions and more (Dominique Anderson only)

This person's Freedom of Information requests (approximately 29)

Periodical Test Results, Maintenance and Testing in Northern Ireland Hospitals?

Response by Department of Health (Northern Ireland) to Dominique Anderson on 21 January 2021.

Awaiting classification.

Dominique With regard to your request below, this information would not be held by the Department. However you may be able to get it by contacti...

Periodical Test Results, Maintenance and Testing in England Hospitals?

Response by NHS England to Dominique Anderson on 21 January 2021.

Awaiting response.

**THIS IS AN AUTOMATED RESPONSE** Dear Customer, Thank you for your email. We are currently receiving a higher than usual volume of emails so...

PCR Swab Test Accuracy SARS-CoV-2 Part 2 Final

Follow up sent to Medicines and Healthcare products Regulatory Agency by Dominique Anderson on 21 January 2021.

Awaiting response.

I look forward to you fulfilling my FOI request. Yours faithfully, Dominique Anderson

PCR Swab Test Accuracy SARS-CoV-2 Part 1

Follow up sent to Medicines and Healthcare products Regulatory Agency by Dominique Anderson on 21 January 2021.

Awaiting response.

I look forward to you fulfilling my FOI request. Yours faithfully, Dominique Anderson

Isolation of SARS-CoV-2 501Y.V2 variants?

Follow up sent to Medicines and Healthcare products Regulatory Agency by Dominique Anderson on 21 January 2021.

Awaiting response.

I look forward to you fulfilling my FOI request. Yours faithfully, Dominique Anderson

Isolation of SARS-CoV-2 N501Y mutation?

Follow up sent to Medicines and Healthcare products Regulatory Agency by Dominique Anderson on 21 January 2021.

Awaiting response.

I look forward to you fulfilling my FOI request. Yours faithfully, Dominique Anderson

Isolation of SARS-CoV-2 VOC 202012/01?

Follow up sent to Medicines and Healthcare products Regulatory Agency by Dominique Anderson on 21 January 2021.

Awaiting response.

I look forward to you fulfilling my FOI request. Yours faithfully, Dominique Anderson

Isolation of SARS-CoV-2 Cluster 5 variant?

Follow up sent to Medicines and Healthcare products Regulatory Agency by Dominique Anderson on 21 January 2021.

Awaiting response.

I look forward to you fulfilling my FOI request. Yours faithfully, Dominique Anderson

Isolation of variant SARS-CoV-2 D614G?

Follow up sent to Medicines and Healthcare products Regulatory Agency by Dominique Anderson on 21 January 2021.

Awaiting response.

I look forward to you fulfilling my FOI request. Yours faithfully, Dominique Anderson

SARS-CoV-2 Coronavirus Antibodies Compared with Natural Immunoglobulin Antibodies?

Follow up sent to Medicines and Healthcare products Regulatory Agency by Dominique Anderson on 20 January 2021.

Awaiting response.

I look forward to you fulfilling my FOI request. Yours faithfully, Dominique Anderson

Pfizer-BioNTech, Oxford-AstraZeneca and Moderna Vaccine Adverse Reactions?

Follow up sent to Medicines and Healthcare products Regulatory Agency by Dominique Anderson on 19 January 2021.

Awaiting response.

I look forward to you fulfilling my FOI request. Yours faithfully, Dominique Anderson

Physiology of mRNA's Inside Body?

Follow up sent to Medicines and Healthcare products Regulatory Agency by Dominique Anderson on 19 January 2021.

Awaiting response.

I look forward to you fulfilling my FOI request. Yours faithfully, Dominique Anderson

Isolation of California Strain Variant B.1.1.7?

Follow up sent to Medicines and Healthcare products Regulatory Agency by Dominique Anderson on 19 January 2021.

Awaiting response.

I look forward to you fulfilling my FOI request. Yours faithfully, Dominique Anderson

Coronavirus Experiments, Risk Assessments, Herd Immunity vs Healthy Immune System

Follow up sent to Medicines and Healthcare products Regulatory Agency by Dominique Anderson on 18 January 2021.

Awaiting response.

I look forward to you fulfilling my FOI request. Yours faithfully, Dominique Anderson

Interferon-Beta Coronavirus Treatment Part 1

Follow up sent to Medicines and Healthcare products Regulatory Agency by Dominique Anderson on 18 January 2021.

Awaiting response.

I look forward to you fulfilling my FOI request. Yours faithfully, Dominique Anderson

Interferon Beta Coronavirus Treatment Part 2

Follow up sent to Medicines and Healthcare products Regulatory Agency by Dominique Anderson on 18 January 2021.

Awaiting response.

I look forward to you fulfilling my FOI request. Yours faithfully, Dominique Anderson

Interferon Beta Coronavirus Treatment Part 3

Follow up sent to Medicines and Healthcare products Regulatory Agency by Dominique Anderson on 18 January 2021.

Awaiting response.

I look forward to you fulfilling my FOI request. Yours faithfully, Dominique Anderson

Interferon Beta Coronavirus Treatment Part 4

Follow up sent to Medicines and Healthcare products Regulatory Agency by Dominique Anderson on 18 January 2021.

Awaiting response.

I look forward to you fulfilling my FOI request. Yours faithfully, Dominique Anderson

Interferon Beta Coronavirus Treatment Part 5

Follow up sent to Medicines and Healthcare products Regulatory Agency by Dominique Anderson on 18 January 2021.

Awaiting response.

I look forward to you fulfilling my FOI request. Yours faithfully, Dominique Anderson

Interferon Beta Coronavirus Treatment Part 7

Follow up sent to Medicines and Healthcare products Regulatory Agency by Dominique Anderson on 18 January 2021.

Awaiting response.

I look forward to you fulfilling my FOI request. Yours faithfully, Dominique Anderson

Interferon Beta Coronavirus Treatment Part 6

Follow up sent to Medicines and Healthcare products Regulatory Agency by Dominique Anderson on 18 January 2021.

Awaiting response.

I look forward to you fulfilling my FOI request. Yours faithfully, Dominique Anderson

Interferon Beta Coronavirus Treatment Part 8

Follow up sent to Medicines and Healthcare products Regulatory Agency by Dominique Anderson on 18 January 2021.

Awaiting response.

I look forward to you fulfilling my FOI request. Yours faithfully, Dominique Anderson

Interferon Beta Coronavirus Treatment Final

Follow up sent to Medicines and Healthcare products Regulatory Agency by Dominique Anderson on 18 January 2021.

Awaiting response.

I look forward to you fulfilling my FOI request. Yours faithfully, Dominique Anderson

Biotechnology Risk Assessment Oxford-AstraZeneca ChAdOx1 nCoV-19 (AZD1222) mRNA vs a Healthy Immune system?

Response by Medicines and Healthcare products Regulatory Agency to Dominique Anderson on 15 January 2021.

Awaiting response.

Our Ref: FOI 21/048 Dear Dominique Anderson, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received...

Isolation of Kent Variant

Response by Medicines and Healthcare products Regulatory Agency to Dominique Anderson on 15 January 2021.

Awaiting response.

Our Ref: FOI 21/047 Dear Dominique Anderson, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received...

This person's annotations

None made.